Oxurion NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oxurion NV with three other
miscellaneous service companies in Europe:
sales of 2.25 million Euros [US$2.73 million]
Peptonic Medical AB
(21.28 million Swedish Kronor [US$2.55 million]
Sprint Bioscience AB
based in SWEDEN
(16.89 million Swedish Kronor [US$2.02 million]
During the year ended December of 2020, sales at
Oxurion NV were 2.08 million Euro (US$2.52 million).
decrease of 47.3%
versus 2019, when the company's sales were 3.95 million Euro.